Switzerland
HBM backs Obseva's CHF 60m series-B
Company develops drugs for reproductive health
Invision acquires majority stake in Schneider Group
Deal marks Invision's first investment for 2015
LifeCare-backed Kuros raises CHF 5m extension
Company has been developing biomaterials since 2000
BlackFin buys New Access Banking Software
Company was founded in 2000
EQT's Sportradar scores $44m funding round
Existing investor EQT stays on board, Michael Jordan joins
Sequana Medical raises CHF 9m series-C extension
New investors Salus Partners and Quest for Growth provide CHF 3.7m
Redalpine scores 10x exit from InSphero
Asset sold to family office
KKR buys Selecta from ACP
GP held minority stake since 2014
Sofinnova backs Asceneuron's CHF 30m series-A
Company is a spin-off from Merck Serono
Mountain Cleantech backs Pessl Instruments
VC injects between €1-5m
SHS and BWK buy minority stake in NDD Medizintechnik
Company operates in Europe, the US and Asia
Montana's third secondary fund closes on €400m hard-cap
Fund has attracted 15 investors
Auven's ADC Therapeutics raises $80m
Company is active in Europe and the US
Björn Böckenförde to leave Zurmont Madison
Böckenförde co-founded the company in 2001
Cequr raises $100m series-C
Insulin infusion device to go on sale next year
Waterland exits Seniocare to Swiss Prime Site
Seniocare acquired three additional homes during holding period
KKR acquires minority stake in Software One
Founding partners and management retain control of the business.
PAI sells Swissport International for CHF 2.7bn
Chinese trade buyer HNA Group picks up asset from PAI
Memo Therapeutics raises CHF 2.3m series-A
Zurich biotech attracts funding from Redalpine
Suikkonen joins Lyrique as partner
Kaarina Suikkonen joins Swiss fund-of-funds manager
Invision appoints new partner
Martin Spirig replaces Gerhard Weisschaedel
VC-backed Biocartis lists with €450m market cap
Biocartis raises €100m in offering
Mountain Partners acquires Netstart Venture
Business angel Kollman sells venture capital company to Swiss VC
HBM Partners backs APR
Swiss firm holds 56% stake alongside Bright Technology Fund